Ethnic differences in rates of Parkinson’s in New Zealand: A nation-wide prevalence and incidence study
Objective: To estimate the prevalence and incidence of Parkinson's in New Zealand and to investigate if these measures differ between the major ethnic groups represented…Predicting poor functional outcome in Parkinson’s disease
Objective: We aimed to describe progression to, identify independent prognostic factors for, and develop a valid prognostic model for, dependency and “death or dependency” in…Falls in Parkinson’s disease : Effects on health related quality of life
Objective: Our aim was to assess the effects of falls in PD patients on HrQoL in PD patients. Background: Health related quality of life (HrQoL)…Promoting optimal physiotherapy practice worldwide: Role of the Association of Physiotherapists in Parkinson’s disease Europe (APPDE)
Objective: To illustrate how the APPDE promotes optimal physiotherapy expertise in Europe and the world in the care of people with Parkinson's. Background: The APPDE…Quality of life and epidemiological profile of patients undergoing botulinum toxin treatment
Objective: To trace a clinical and epidemiological profile of patients treated with botulinum toxin, evaluating the impact on quality of life. Background: The Botulinum Toxin…Can body worn cameras help us understand the complex relationship between physical activity and falls in people with Parkinson’s?
Objective: To explore barriers and facilitators to physical activity and examine the relationship with falls for people with Parkinson's (PwP) using body worn cameras. Background:…Clinically ‘slight’ bradykinesia in Parkinson’s disease is accurately detected using evolutionary computation analysis of finger tapping
Objective: To assess whether MDS-UPDRS grade one Parkinson's disease (PD) bradykinesia can be accurately detected by a novel non-invasive device that analyses a standard finger…Evaluation of kinematic parameters of potential clinical use extracted from Microsoft Kinect V2 motor assessments
Objective: To evaluate movement parameters for clinical use extracted from Microsoft Kinect V2 joints. Background: Instrumental motor assessment has been proposed to increase objectivity but…The relevance of movement disorders gene panels in clinical practice: How many patients are we sorting out?
Objective: To investigate the impact of movement disorder gene panels in clinical practice and the proportion of patients receiving a definite genetic diagnosis through Next…The distinguishing clinical features of rapid-onset-parkinson-dystonia (RDP) syndrome due to ATP1A3 mutations
Objective: To determine characteristics that distinguish individuals with presentation suggestive of RDP in ATP1A3 mutation carriers compared with non-carriers. Background: Mutations in the ATP1A3 gene…
- « Previous Page
- 1
- …
- 105
- 106
- 107
- 108
- 109
- …
- 207
- Next Page »